North America held a dominan Market position, capturing more than a 38.7% share, holding USD 351.3 Million revenue.
CLASSIC enables large-scale testing of complex DNA circuits in human cells, advancing data-driven synthetic biology.
1 天on MSNOpinion
Could Kemi Badenoch be our next prime minister?
Tory leader Kemi Badenoch has several critical personal talents that are not easily replicated, and the polls are starting to ...
Tech Xplore on MSN
What can technology do to stop AI-generated sexualized images?
The global outcry over the sexualization and nudification of photographs—including of children—by Grok, the chatbot developed by Elon Musk's artificial intelligence company xAI, has led to urgent ...
Beverly Geiger Bonnheim was 17 when the Ku Klux Klan bombed her synagogue in 1967. This weekend, at 75, she watched it burn ...
The Great Red Spot is a gigantic storm, twice the size of Earth, that has swirled for centuries. It’s just one of many on the ...
While investors chase high-profile AI chip makers and tech giants, a quieter transformation is unfolding across traditional ...
Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth-quarter 2025 investor letter ...
A Dell-tested NVIDIA N1X laptop just resurfaced in a recent test record. It’s a solid hint Nvidia’s laptop processor plans ...
SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- MediKarma today announced a defining strategic shift with the launch of its Agentic AI Licensing Program, making it the first company in the healthcare ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果